MedTrace Logo

Non-invasive, Wearable Multi-parameter System for the Early Prediction of Cognitive Decline and Dementia in Older Adults

NCT04262674 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2021-02-04

No results posted yet for this study

Summary

This project develops an innovative screening system and prediction model to detect preclinical symptoms of cognitive impairment and predict the potential development of mild cognitive impairments and dementia in older adults. The earliest possible detection of preclinical symptoms is prerequisite to improve the efficacy of subsequent preventative non-pharmacological, life-style and exercise related, personalized treatment interventions.

Conditions

Interventions

OTHER

Cognitive-motor training

Simultaneous cognitive-motor training and strength training

Sponsors & Collaborators

  • Geriatrische Klinik St. Gallen

    collaborator OTHER

  • ETH Zurich

    collaborator OTHER

  • Empa, Swiss Federal Laboratories for Materials Science and Technology

    lead OTHER

Principal Investigators

  • Patrick Eggenberger, Dr. · Empa, Swiss Federal Laboratories for Materials Science and Technology

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-23
Primary Completion
2021-05-31
Completion
2021-07-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04262674 on ClinicalTrials.gov